In the latest issue of Drug Discovery and Development, Joanna Pulawska, Ph.D. Therapeutic Area Head, CNS, highlights key considerations for advancing neurodegenerative drug development, and while earlier intervention is feasible, it requires new trial strategies. The article covers how data sharing, biomarkers and cross-industry collaborations are making it possible.

READ FULL ARTICLE: https://www.calameo.com/read/008183692bdb242350f10?trackersource=library